AB146939
MW 479.93 g/mol, Purity >98%. NVS-PAK1-1 is a potent allosteric inhibitor of p21-activated kinase PAK1. It has an IC50 value of 5 nM for dephoshorylated PAK1 and 6 nM for phosphorylated PAK1 in an in vitro assay. It is more than 50-fold more active against PAK1 than against PAK2. NVS-PAK1-1 is highly selective in a panel of 442 kinases. NVS-PAK1-1 potently inhibits PAK1 autophosphorylation in cell-based assays.
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
ACS medicinal chemistry letters 6:776-81 PubMed26191365
2015
Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor.
Applications
Unspecified application
Species
Unspecified reactive species
Alexei S Karpov,Payman Amiri,Cornelia Bellamacina,Marie-Helene Bellance,Werner Breitenstein,Dylan Daniel,Regis Denay,Doriano Fabbro,Cesar Fernandez,Inga Galuba,Stephanie Guerro-Lagasse,Sascha Gutmann,Linda Hinh,Wolfgang Jahnke,Julia Klopp,Albert Lai,Mika K Lindvall,Sylvia Ma,Henrik Möbitz,Sabina Pecchi,Gabriele Rummel,Kevin Shoemaker,Joerg Trappe,Charles Voliva,Sandra W Cowan-Jacob,Andreas L Marzinzik
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com